贝达药业股份有限公司成立于2003年，总部位于浙江杭州，是一家由海归高层次人才团队创办的、以自主知识产权创新药物研究和开发为核心，集研发、生产、营销于一体的国家级高新技术企业。电话：0571-86130357
Employees: 1001-5000
Investors 3
| Date | Name | Website |
| - | LAV | lavfund.co... |
| - | China Ever... | everbright... |
| - | Cowin Capi... | cowincapit... |
Mentions in press and media 5
| Date | Title | Description |
| 18.08.2026 | China's Betta Pharma Hits Limit-Down After Duravyu Fails to Match Rival Eye Drug | (Yicai) Aug. 18 -- Shares of China's Betta Pharmaceuticals plunged by the daily limit today after its US partner EyePoint said a late-stage trial of their jointly developed eye disease drug Duravyu failed to show it worked at least as well ... |
| 17.06.2026 | Could replacement technology become longevity medicine’s next frontier? | Around 1000 BC, Tabaket-en-Mut, the daughter of an ancient Egyptian priest, likely never imagined that the wooden prosthesis she wore after losing her big toe would become a piece of medical history some 3,000 years later. Archaeologists be... |
| 29.01.2026 | XtalPi Convenes Global Experts to Shape the Future of Molecular Glue Drug Discovery: From Serendipity to Precision | Global thought leaders presented cutting-edge research at the 2026 International Symposium on Molecular Glue Drug Discovery. XtalPi unveils the AI-driven XGlue™ platform to enable rapid, closed-loop molecular glue drug discovery. Cross-sect... |
| 04.01.2024 | C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals | - |
| 29.10.2014 | Xcovery Raises $20M Equity Investment | Xcovery, a West Palm Beach, FL-based developer of targeted therapeutics for cancer, raised a $20m equity investment from Betta Pharmaceuticals Co., a Chinese pharmaceutical company focused on discovering, developing and delivering innovativ... |